市場調查報告書
商品編碼
1499501
D-胺基酸市場:按類型、產品和最終用途分類 - 全球預測 2024-2030D-Amino Acids Market by Type (Natural, Synthetic), Product (D-Alanine, D-Aspartic Acid, D-Glutamic Acid), End-Use - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
D-胺基酸市場規模預計2023年為1.9171億美元,2024年達到2.0032億美元,預計2030年將達到2.6235億美元,複合年成長率為4.58%。
D-胺基酸是一種具有多種應用的掌性分子。 D-胺基酸是自然界中廣泛存在的L-胺基酸的對映體。 D-胺基酸因其獨特的性質而引起人們的關注,並擴大應用於製藥、生物技術、食品和飼料工業以及研究應用。由於製藥工業的不斷擴張以及對功效和安全性提高的新藥的需求不斷增加,對 D-氨基酸的需求不斷增加。 D-胺基酸合成和應用創新技術的開拓將推動市場成長。此外,全球健康意識的增強和對飲食習慣的興趣也推動了食品和飼料行業對 D-氨基酸的需求。 D-胺基酸生產的複雜性和成本不斷增加阻礙了市場的成長,特別是在考慮大規模合成時。對映選擇性合成新技術的新興市場開拓預計將導致成本降低和效率提高,從而創造市場成長機會。生物催化的創新和醫學新應用的發現,例如胜肽的設計,為市場成長提供了進一步的潛力。與研究機構在神經科學和代謝疾病方面的新應用的合作也為 D-氨基酸市場提供了潛在的成長機會。
主要市場統計 | |
---|---|
基準年[2023] | 1.9171 億美元 |
預測年份 [2024] | 2億美元 |
預測年份 [2030] | 26235萬美元 |
複合年成長率(%) | 4.58% |
區域洞察
由於對生物技術和藥物研究的大量投資,美洲的 D-氨基酸市場仍然強勁。消費者的需求集中在創新配方和胜肽療法的開發。不斷發展的生物技術產業擴大購買這些專用胺基酸用於研究和產品開發。慢性病的流行和個人化醫療的推動進一步增加了南美洲對 D-氨基酸的需求。歐盟 (EU) 的製藥工業十分完善,對 D-胺基酸的穩定需求主要由新配方的研發驅動。歐盟法規鼓勵創新,這體現在成員國 D-胺基酸專利申請數量穩定。對品質和法規合規性的關注正在影響該地區消費者的購買行為。歐盟對生命科學和生物技術研究的投資正在支持 D-氨基酸市場的成長。在中東和非洲,研究機構投資的增加和醫療保健領域的擴張表明 D-氨基酸市場擴張的潛力。由於龐大的製藥產業及其在全球供應鏈中的地位,亞太地區D-胺基酸市場正在不斷擴大和成長。亞太地區D-胺基酸新用途的拓展反映了該國研發投資的規模,大量的研究資料和專利就證明了這一點。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在 D-胺基酸市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對 D-胺基酸市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對當前 D-氨基酸市場地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[182 Pages Report] The D-Amino Acids Market size was estimated at USD 191.71 million in 2023 and expected to reach USD 200.32 million in 2024, at a CAGR 4.58% to reach USD 262.35 million by 2030.
The D-amino acids are a class of chiral molecules used in various applications. D-amino acids are the enantiomers of naturally prevalent L-amino acids. D-amino acids have gained attention due to their unique properties and increasing use in pharmaceuticals, biotechnology, food and feed industries, and research applications. The pharmaceutical industry is continuously expanding, and there is an increased demand for novel drugs with improved efficacy and safety, creating the need for D-amino acids. The development of innovative technologies for the synthesis and application of D-amino acids fosters market growth. The rise in health awareness and dietary concerns among the global population also propels the demand for D-amino acids in the food and feed sectors. Rising complexity and increasing cost of production of D-amino acids, particularly when considering large-scale synthesis, is hampering the market growth. The rising development of new methods for enantioselective synthesis can lead to cost reduction, and greater efficiency is expected to create opportunities for market growth. Innovations in biocatalysis and the discovery of new applications in medical science, such as in antimicrobial peptide design, provide additional scope for market growth. Collaboration with research institutions for novel applications in neurosciences and metabolic disorders also presents potential opportunities for the growth of the D-amino acids market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 191.71 million |
Estimated Year [2024] | USD 200.32 million |
Forecast Year [2030] | USD 262.35 million |
CAGR (%) | 4.58% |
Regional Insights
The market for D-Amino Acids in the Americas is robust, driven by substantial investments in biotechnology and pharmaceutical research. Consumer needs revolve around innovative drug formulations and the development of peptide-based therapeutics. The growing biotech sector has seen an uptick in purchasing these specialized amino acids for research and product development. The prevalence of chronic diseases and the push for personalized medicine further bolster demand for D-amino acids in South America. The European Union has a well-established pharmaceutical industry with a steady demand for D-amino acids, primarily driven by research and development in novel drug formulations. EU regulations encourage innovation, which is reflected in the steady number of patents being filed relating to D-amino acids within member countries. Emphasis on quality and regulatory compliance influences consumer purchasing behavior in this region. The EU's investment in life sciences and biotechnology research initiatives supports the growth of the D-amino acids market. In the Middle East and Africa, increased investment in research institutions and expansion of healthcare sectors suggest a growing market potential for D-amino acids. Asia-Pacific's D-amino acids market is expansive and growing due to its massive pharmaceutical sector and global supply chain position. The country's significant R&D investment, evidenced by a high volume of research materials and patents, demonstrates the expansion of novel applications for D-amino acids in the Asia-Pacific region.
Market Insights
The market dynamics represent an ever-changing landscape of the D-Amino Acids Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the D-Amino Acids Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the D-Amino Acids Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Grand Pharma Acquired 100% Equity of Hubei Bafeng, Further Expanding the Strategic Plan on High-quality Amino Acid Industry
Grand Pharmaceutical Group Limited announced the strategic acquisition of Hubei Bafeng Pharmaceuticals and Chemicals Share Co., Ltd. for RMB 270 million. This important move follows their acquisition of Cangzhou Huachen BioTech Co., Ltd. in 2021, reinforcing their expansion within the amino acid industry. [Published On: 2023-08-08]
CJ do Brasil Invests ZAR 1.1 Billion and Expands Amino Acid Factory in Piracicaba
CJ do Brasil, a branch of the international powerhouse CJ Bio, celebrated a significant milestone with expanding its Piracicaba facility, roughly 160 kilometers from Sao Paulo. This ZAR 1.1 billion investment anticipates creating 650 new jobs and fortifies the company's unique position in Latin America as the only producer of three vital amino acids for animal nutrition: Lysine, Threonine, and Tryptophan. [Published On: 2023-05-31]
Evonik Strengthens Competitiveness of its Animal Nutrition Business
Evonik announced partitioning its operations into two dedicated segments: amino acids and specialty nutrition, each aligned with specific market demands and conditions. The amino acid sector aims to harness streamlined processes and digital prowess to boost efficiency and maintain cost-competitiveness, while the specialty nutrition segment aims to evolve towards integrated system solutions, emphasizing functional feed additives and digital tools for various livestock categories. [Published On: 2023-04-03]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the D-Amino Acids Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the D-Amino Acids Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Amino GmbH, AnaSpec, Inc, Archer-Daniels-Midland Company, Bachem AG, Cargill, Incorporated, Central Drug House (P) Ltd., Creative Enzymes, Evonik Industries AG, IRIS Biotech GmbH, Kyowa Hakkon Kirin Co. Ltd., LG Chem Ltd., Matter and Form Inc., Pepscan, Prinova Group LLC, Sekisui Medical Co. Ltd., Shanghai Brightol International, Shijiazhuang Haitian Amino Acid Co., Ltd., Sichuan Tongsheng Amino acid Co., Ltd., Tokyo Chemical Industry Co., Ltd., Varsal Chemicals, Wacker Chemie AG, Wuhan Amino Acid Bio-Chemical Co., Ltd, Yoneyama Yakuhin Kogyo Co., Ltd., and Zhangjiagang Huachang Pharmaceutical Co. Ltd..
Market Segmentation & Coverage